Arkema shares regain the 57.50 € level ahead of its November 5 results
The specialty chemicals company benefits from a well-oriented session in Paris and moves back above a technical threshold identified a month ago. The publication of its quarterly results is expected shortly afterwards.
A 30-session threshold cleared, the MM200 remains within reach
Shares in Arkema gain 2.12% to 57.70 € and rise above 57.50 €, its highest level of the last 30 sessions, which has now become support. The breakout occurred during the session and the stock is holding it, with a last price at 57.75 €.
The price remains slightly below the MM200, at 58.10 €, i.e. 0.7% higher, although it has already recovered its MM20 and MM50.
The RSI at 63 accompanies this rebound without signaling excess. The stock is up 4.5% over the week and 7.2% over the month, but still down 5.6% over three months. It follows a CAC 40 rising 2.16% and an SBF 120 up 2.04%, in a market supported by the decline of the VIX to 17.41.
Third-quarter results on Thursday, November 5, following SBTi validation
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
Arkema publishes its third-quarter results on Thursday, November 5, an event the stock approaches at 57.70 €. At the time of the first-quarter release on May 6, EBITDA had declined 14%, with margins under pressure. The group subsequently raised its EBITDA by 7.4% in the second quarter and confirmed its annual guidance at the end of July.
On Tuesday, November 3, the chemicals company announced the validation by the SBTi of a net-zero target for 2050, a first in the chemicals sector according to the press release. On the technical side, the next resistance lies at 65.20 €, while the 57.50 € support is the level the stock has just reclaimed.
« Nous ne prévoyons pas d'amélioration des conditions externes dans les prochains mois »
Outlook / guidance
Management commentary: « Arkema est en ligne avec son objectif de réaliser un EBITDA 2026 légèrement supérieur à l'an dernier à taux de change constants »
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.
